作者: Duanyang Zhang , Weicen Liu , Zhonghua Wen , Bing Li , Shuling Liu
关键词:
摘要: Anthrax caused by Bacillus anthracis is a lethal infectious disease, especially when inhaled, and the mortality rate approaches 100% without treatment. The anthrax antitoxin monoclonal antibody (MAb) 5E11 humanized that targets protective antigen (PA). efficacy of needs proper animal models. However, spores are extremely dangerous, so experiments must be conducted under Biosafety Level 3 conditions. Considering critical effects toxin (LT) on hosts during infection, we report establishment LT-challenged rabbit model, which with dose 2 mg PA + 1 LF, while 4 LF challenge could limit death to within three days. Then, evaluated against LT. A prophylactic study showed i.v. administration 40 mg/kg four days before LT lead survival. In therapeutic studies, 10 min after provide complete protection. Overall, developed new our results indicate shows potential for clinical application in